ICO Curazion - The output of medicine to a new level
The startup intends to improve medical care, reduce certain costs and ultimately save the lives of a large number of people. Curazion project can be called even a revolution in the health sector.
In fact, a huge problem is being solved, namely, the issue of helping the correct use of the drug is being solved. To be honest, every day millions of people do not take medicines in accordance with the recommendations and, accordingly, huge expenses flow from here.
The data on which the project is working are very unique and at the same time have a huge weight for most pharmaceutical companies, including researchers.
At a time when patients use the CuraServe technology itself, all the data about which we have already talked are gaining even more weight. Such innovative technologies will greatly help to better control people's lives. There is some anonymous collection of data on how and when patients take medication.
Data will be accessed through internal tokens. Also, due to the tokens, the costs will be significantly reduced, as well as the rapid promotion of medical research will be carried out.
As we have already said, the project is aimed at helping people to improve the quality of life in General, now the percentage of sudden death or disability will be significantly reduced. The very same social benefits of the project is very significant.
This development will be relevant based on the statistics of the market of medical analyzers. Cash turnover in this sector will reach $ 24.55 billion by 2021. Speaking about the statistics of 2016, it was $ 7.39 billion. As you can see, the dynamics is very serious.
At the expense of the next generation of big data and some of the analysis tools, namely due to CuraData, we have a democratization for all data and thus to all stakeholders. Such solutions will support a variety of regulations to guide and significantly speed up the development of medicines that improve the treatment of chronic and prolonged illness.
Another advantage that I want to highlight is the saving of money. After all, you will agree that reducing costs and reducing health care costs has an important role in obtaining efficiency in General.
2018 (August) - start of public token sale
2018 (November) - launch of CuraData beta
2019 (February) - official release of CuraData
2019 (March) - completion of clinical trials and launch of CuraServe
2019 (April) - Deployment to key markets
2019 (July) - Active development and scaling of the technology
2020 - launch of CuraData 2.0 which implies fully integrated and full-featured data trading.
The tokens carry the CTKN label, which in turn allows holders to access our own and anonymous medical data on the blockchain itself. Holders get access to data that contains very powerful Analytics, big data of artificial intelligence and so on. Tokens also greatly promote partnerships with medical and pharmaceutical organizations through a system with certain rewards.
Total token supply: 500 000 000 CTKN
What does the token distribution look like ??
50% - Allocated for sale
15% is Allotted to the partners of the project
20% - for reward programs, as well as for advisors
15% - Allocated for the team
The cost of tokens at the time of ICO: 0.2 $
Minimum investment: $500
Hard Cap: 25 000 000 $
End of ICO: October 31
Author BTT - https://bitcointalk.org/index.php?action=profile;u=1731968
Malibu CHAT - https://bit.ly/2QePV1v